OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 482.84 Million USD | 8.58% |
| 2022 | 444.7 Million USD | -3.53% |
| 2021 | 460.99 Million USD | 1.43% |
| 2020 | 454.47 Million USD | 30.11% |
| 2019 | 349.29 Million USD | 10.69% |
| 2018 | 315.57 Million USD | 6.54% |
| 2017 | 296.2 Million USD | 42.45% |
| 2016 | 207.93 Million USD | 9.83% |
| 2015 | 189.32 Million USD | -0.16% |
| 2014 | 189.63 Million USD | 2.92% |
| 2013 | 184.24 Million USD | -3.9% |
| 2012 | 191.72 Million USD | 49.95% |
| 2011 | 127.86 Million USD | 4.36% |
| 2010 | 122.52 Million USD | -3.52% |
| 2009 | 126.99 Million USD | -3.74% |
| 2008 | 131.91 Million USD | -21.17% |
| 2007 | 167.35 Million USD | 6.89% |
| 2006 | 156.56 Million USD | 19.75% |
| 2005 | 130.74 Million USD | 48.47% |
| 2004 | 88.06 Million USD | 2.22% |
| 2003 | 86.15 Million USD | 141.07% |
| 2002 | 35.73 Million USD | -4.15% |
| 2001 | 37.28 Million USD | -1.2% |
| 2000 | 37.73 Million USD | 252.67% |
| 1999 | 10.7 Million USD | 2.88% |
| 1998 | 10.4 Million USD | -38.82% |
| 1997 | 17 Million USD | -62.39% |
| 1996 | 45.2 Million USD | 50.17% |
| 1995 | 30.1 Million USD | 22.36% |
| 1994 | 24.6 Million USD | 74.47% |
| 1993 | 14.1 Million USD | -10.19% |
| 1992 | 15.7 Million USD | 3.29% |
| 1991 | 15.2 Million USD | 137.5% |
| 1990 | 6.4 Million USD | -20.99% |
| 1989 | 8.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 466.34 Million USD | -0.26% |
| 2024 Q1 | 467.55 Million USD | -3.17% |
| 2023 Q2 | 453.59 Million USD | -1.27% |
| 2023 Q3 | 458.43 Million USD | 1.07% |
| 2023 Q4 | 482.84 Million USD | 5.33% |
| 2023 FY | 482.84 Million USD | 8.58% |
| 2023 Q1 | 459.41 Million USD | 3.31% |
| 2022 Q2 | 429.25 Million USD | -1.44% |
| 2022 Q3 | 432.2 Million USD | 0.69% |
| 2022 Q4 | 444.7 Million USD | 2.89% |
| 2022 Q1 | 435.53 Million USD | -5.52% |
| 2022 FY | 444.7 Million USD | -3.53% |
| 2021 FY | 460.99 Million USD | 1.43% |
| 2021 Q4 | 460.99 Million USD | 1.15% |
| 2021 Q3 | 455.75 Million USD | -2.0% |
| 2021 Q2 | 465.04 Million USD | 1.87% |
| 2021 Q1 | 456.49 Million USD | 0.45% |
| 2020 Q3 | 436.41 Million USD | 3.7% |
| 2020 Q2 | 420.82 Million USD | 29.46% |
| 2020 Q1 | 325.07 Million USD | -6.93% |
| 2020 FY | 454.47 Million USD | 30.11% |
| 2020 Q4 | 454.47 Million USD | 4.14% |
| 2019 FY | 349.29 Million USD | 10.69% |
| 2019 Q3 | 339.22 Million USD | 3.59% |
| 2019 Q4 | 349.29 Million USD | 2.97% |
| 2019 Q1 | 318.92 Million USD | 1.06% |
| 2019 Q2 | 327.46 Million USD | 2.68% |
| 2018 Q1 | 285.92 Million USD | -3.47% |
| 2018 FY | 315.57 Million USD | 6.54% |
| 2018 Q4 | 315.57 Million USD | 3.7% |
| 2018 Q3 | 304.3 Million USD | 4.09% |
| 2018 Q2 | 292.36 Million USD | 2.25% |
| 2017 FY | 296.2 Million USD | 42.45% |
| 2017 Q3 | 282.25 Million USD | 9.25% |
| 2017 Q1 | 232.59 Million USD | 11.86% |
| 2017 Q4 | 296.2 Million USD | 4.94% |
| 2017 Q2 | 258.35 Million USD | 11.07% |
| 2016 Q2 | 199.92 Million USD | 6.07% |
| 2016 Q4 | 207.93 Million USD | 2.15% |
| 2016 Q1 | 188.47 Million USD | -0.44% |
| 2016 FY | 207.93 Million USD | 9.83% |
| 2016 Q3 | 203.55 Million USD | 1.82% |
| 2015 Q3 | 193.84 Million USD | 7.65% |
| 2015 Q1 | 177.64 Million USD | -6.32% |
| 2015 Q2 | 180.07 Million USD | 1.37% |
| 2015 FY | 189.32 Million USD | -0.16% |
| 2015 Q4 | 189.32 Million USD | -2.33% |
| 2014 FY | 189.63 Million USD | 2.92% |
| 2014 Q2 | 179.56 Million USD | 3.15% |
| 2014 Q3 | 190.5 Million USD | 6.09% |
| 2014 Q4 | 189.63 Million USD | -0.46% |
| 2014 Q1 | 174.08 Million USD | -5.52% |
| 2013 Q2 | 174.42 Million USD | -4.18% |
| 2013 Q3 | 178.21 Million USD | 2.17% |
| 2013 Q4 | 184.24 Million USD | 3.39% |
| 2013 FY | 184.24 Million USD | -3.9% |
| 2013 Q1 | 182.03 Million USD | -5.05% |
| 2012 Q4 | 191.72 Million USD | -2.46% |
| 2012 Q2 | 124.73 Million USD | 0.05% |
| 2012 Q3 | 196.55 Million USD | 57.58% |
| 2012 Q1 | 124.67 Million USD | -2.49% |
| 2012 FY | 191.72 Million USD | 49.95% |
| 2011 FY | 127.86 Million USD | 4.36% |
| 2011 Q3 | 122.8 Million USD | 1.28% |
| 2011 Q4 | 127.86 Million USD | 4.12% |
| 2011 Q1 | 119.19 Million USD | -2.72% |
| 2011 Q2 | 121.25 Million USD | 1.73% |
| 2010 Q1 | 121.11 Million USD | -4.63% |
| 2010 FY | 122.52 Million USD | -3.52% |
| 2010 Q4 | 122.52 Million USD | 0.83% |
| 2010 Q3 | 121.5 Million USD | -1.96% |
| 2010 Q2 | 123.93 Million USD | 2.33% |
| 2009 Q3 | 127.67 Million USD | 4.67% |
| 2009 Q1 | 126.76 Million USD | -3.91% |
| 2009 FY | 126.99 Million USD | -3.74% |
| 2009 Q4 | 126.99 Million USD | -0.54% |
| 2009 Q2 | 121.97 Million USD | -3.77% |
| 2008 Q1 | 164.3 Million USD | -1.82% |
| 2008 FY | 131.91 Million USD | -21.17% |
| 2008 Q2 | 164.42 Million USD | 0.07% |
| 2008 Q3 | 159.01 Million USD | -3.29% |
| 2008 Q4 | 131.91 Million USD | -17.04% |
| 2007 Q4 | 167.35 Million USD | 3.65% |
| 2007 FY | 167.35 Million USD | 6.89% |
| 2007 Q2 | 159.84 Million USD | 2.37% |
| 2007 Q1 | 156.14 Million USD | -0.27% |
| 2007 Q3 | 161.45 Million USD | 1.01% |
| 2006 FY | 156.56 Million USD | 19.75% |
| 2006 Q3 | 149.73 Million USD | 2.9% |
| 2006 Q1 | 130.75 Million USD | 0.01% |
| 2006 Q2 | 145.51 Million USD | 11.29% |
| 2006 Q4 | 156.56 Million USD | 4.56% |
| 2005 Q1 | 89.18 Million USD | 1.28% |
| 2005 FY | 130.74 Million USD | 48.47% |
| 2005 Q4 | 130.74 Million USD | 30.18% |
| 2005 Q3 | 100.43 Million USD | 8.17% |
| 2005 Q2 | 92.85 Million USD | 4.11% |
| 2004 FY | 88.06 Million USD | 2.22% |
| 2004 Q1 | 85.31 Million USD | -0.97% |
| 2004 Q3 | 86.72 Million USD | -1.2% |
| 2004 Q4 | 88.06 Million USD | 1.54% |
| 2004 Q2 | 87.78 Million USD | 2.89% |
| 2003 Q1 | 36.06 Million USD | 0.91% |
| 2003 Q3 | 38.95 Million USD | 6.63% |
| 2003 FY | 86.15 Million USD | 141.07% |
| 2003 Q2 | 36.53 Million USD | 1.29% |
| 2003 Q4 | 86.15 Million USD | 121.17% |
| 2002 Q3 | 33.36 Million USD | 0.17% |
| 2002 Q4 | 35.73 Million USD | 7.11% |
| 2002 Q1 | 34.4 Million USD | -7.73% |
| 2002 Q2 | 33.31 Million USD | -3.17% |
| 2002 FY | 35.73 Million USD | -4.15% |
| 2001 Q1 | 35.45 Million USD | -6.04% |
| 2001 Q2 | 37.21 Million USD | 4.94% |
| 2001 Q3 | 38.47 Million USD | 3.4% |
| 2001 Q4 | 37.28 Million USD | -3.1% |
| 2001 FY | 37.28 Million USD | -1.2% |
| 2000 Q2 | 21.59 Million USD | 26.08% |
| 2000 FY | 37.73 Million USD | 252.67% |
| 2000 Q4 | 37.73 Million USD | -15.16% |
| 2000 Q1 | 17.12 Million USD | 70.1% |
| 2000 Q3 | 44.48 Million USD | 105.96% |
| 1999 Q1 | 10.7 Million USD | 11.46% |
| 1999 Q3 | 10.7 Million USD | 2.88% |
| 1999 Q4 | 10.06 Million USD | -5.89% |
| 1999 Q2 | 10.4 Million USD | -2.8% |
| 1999 FY | 10.7 Million USD | 2.88% |
| 1998 Q2 | 10 Million USD | -0.99% |
| 1998 Q4 | 9.6 Million USD | -7.69% |
| 1998 FY | 10.4 Million USD | -38.82% |
| 1998 Q1 | 10.1 Million USD | -9.82% |
| 1998 Q3 | 10.4 Million USD | 4.0% |
| 1997 Q3 | 17 Million USD | -28.27% |
| 1997 FY | 17 Million USD | -62.39% |
| 1997 Q1 | 30 Million USD | -26.65% |
| 1997 Q2 | 23.7 Million USD | -21.0% |
| 1997 Q4 | 11.2 Million USD | -34.12% |
| 1996 Q4 | 40.9 Million USD | -9.51% |
| 1996 Q1 | 27.4 Million USD | -2.49% |
| 1996 Q2 | 34.1 Million USD | 24.45% |
| 1996 Q3 | 45.2 Million USD | 32.55% |
| 1996 FY | 45.2 Million USD | 50.17% |
| 1995 Q1 | 31.6 Million USD | 34.47% |
| 1995 Q2 | 33.3 Million USD | 5.38% |
| 1995 Q3 | 30.1 Million USD | -9.61% |
| 1995 Q4 | 28.1 Million USD | -6.64% |
| 1995 FY | 30.1 Million USD | 22.36% |
| 1994 FY | 24.6 Million USD | 74.47% |
| 1994 Q4 | 23.5 Million USD | -4.47% |
| 1994 Q3 | 24.6 Million USD | -8.21% |
| 1994 Q2 | 26.8 Million USD | 44.86% |
| 1994 Q1 | 18.5 Million USD | 28.47% |
| 1993 FY | 14.1 Million USD | -10.19% |
| 1993 Q1 | 15.9 Million USD | -17.19% |
| 1993 Q2 | 13.2 Million USD | -16.98% |
| 1993 Q3 | 14.1 Million USD | 6.82% |
| 1993 Q4 | 14.4 Million USD | 2.13% |
| 1992 Q2 | 18.1 Million USD | 39.23% |
| 1992 Q1 | 13 Million USD | -2.99% |
| 1992 FY | 15.7 Million USD | 3.29% |
| 1992 Q3 | 15.7 Million USD | -13.26% |
| 1992 Q4 | 19.2 Million USD | 22.29% |
| 1991 Q3 | 15.2 Million USD | 53.54% |
| 1991 Q2 | 9.9 Million USD | -4.81% |
| 1991 Q1 | 10.4 Million USD | 19.54% |
| 1991 FY | 15.2 Million USD | 137.5% |
| 1991 Q4 | 13.4 Million USD | -11.84% |
| 1990 Q2 | 6.6 Million USD | -8.33% |
| 1990 FY | 6.4 Million USD | -20.99% |
| 1990 Q3 | 6.4 Million USD | -3.03% |
| 1990 Q1 | 7.2 Million USD | -10.0% |
| 1990 Q4 | 8.7 Million USD | 35.94% |
| 1989 FY | 8.1 Million USD | 0.0% |
| 1989 Q4 | 8 Million USD | -1.23% |
| 1989 Q2 | 8.1 Million USD | 0.0% |
| 1989 Q3 | 8.1 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -167.698% |
| AngioDynamics, Inc. | 317.67 Million USD | -51.995% |
| AtriCure, Inc. | 613.93 Million USD | 21.352% |
| Avinger, Inc. | 13.77 Million USD | -3406.5% |
| Azenta, Inc. | 2.88 Billion USD | 83.268% |
| BioLife Solutions, Inc. | 412.71 Million USD | -16.993% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 95.859% |
| Daxor Corporation | 34.86 Million USD | -1284.734% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -1569.704% |
| Femasys Inc. | 27.75 Million USD | -1639.617% |
| GlucoTrack, Inc. | 4.9 Million USD | -9743.935% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -251.503% |
| Hologic, Inc. | 9.15 Billion USD | 94.726% |
| ICU Medical, Inc. | 4.37 Billion USD | 88.972% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 96.873% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -1596.516% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -39.237% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -7664.327% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -7664.327% |
| Masimo Corporation | 3.04 Billion USD | 84.125% |
| Microbot Medical Inc. | 8.32 Million USD | -5698.547% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -180.862% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 79.235% |
| Nephros, Inc. | 11.86 Million USD | -3970.862% |
| NovoCure Limited | 1.14 Billion USD | 57.872% |
| NEXGEL, Inc. | 9.95 Million USD | -4750.276% |
| NEXGEL, Inc. | 9.95 Million USD | -4750.276% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -81.885% |
| Pro-Dex, Inc. | 54.21 Million USD | -790.694% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -694.101% |
| Predictive Oncology Inc. | 14.41 Million USD | -3249.079% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -2754.947% |
| QuidelOrtho Corporation | 8.56 Billion USD | 94.361% |
| Repligen Corporation | 2.82 Billion USD | 82.905% |
| Sanara MedTech Inc. | 73.87 Million USD | -553.631% |
| STAAR Surgical Company | 488.69 Million USD | 1.196% |
| Sharps Technology, Inc. | 11.78 Million USD | -3995.632% |
| Utah Medical Products, Inc. | 135.45 Million USD | -256.454% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 93.449% |
| Jin Medical International Ltd. | 32.9 Million USD | -1367.46% |